The European Medicines Agency (EMA) announced on Tuesday April 20 that blood clots should be listed as a "very rare" side effect of the Johnson & Johnson vaccine against Covid-19, while believing that the benefits outweigh on the risks.
The European regulator said in a statement to have established a "possible link" between the vaccine of the American laboratory Johnson & Johnson and cases of blood clots, which should "be listed as very rare side effects of the vaccine."
>> To read also: "Covid-19: Johnson & Johnson 'delays the deployment' of its vaccine in Europe"
With AFP
The summary of the week
France 24 invites you to come back to the news that marked the week
I subscribe
Take international news everywhere with you!
Download the France 24 application
google-play-badge_FR